Published in BMC Proc on March 10, 2009
The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol (2006) 30.90
An E-M algorithm and testing strategy for multiple-locus haplotypes. Am J Hum Genet (1995) 13.84
Dopa decarboxylase (Ddc) affects variation in Drosophila longevity. Nat Genet (2003) 2.56
Database development in toxicogenomics: issues and efforts. Environ Health Perspect (2004) 2.26
Microarrays and toxicology: the advent of toxicogenomics. Mol Carcinog (1999) 2.12
Distributed structure-searchable toxicity (DSSTox) public database network: a proposal. Mutat Res (2002) 1.27
Single nucleotide polymorphism in transcriptional regulatory regions and expression of environmentally responsive genes. Toxicol Appl Pharmacol (2005) 1.19
Genes related to apoptosis predict necrosis of the liver as a phenotype observed in rats exposed to a compendium of hepatotoxicants. BMC Genomics (2008) 1.14
Molecular responses to xenoestrogens: mechanistic insights from toxicogenomics. Toxicology (2005) 0.96
Empowering microarrays in the regulatory setting. Nat Biotechnol (2006) 0.90
Temperature-dependent regulation of proteins in Aspergillus flavus: whole organism stable isotope labeling by amino acids. J Proteome Res (2008) 0.90
Environmental health moves into the 21st century. Int J Hyg Environ Health (2003) 0.83
In pursuit of effective toxicogenomics. Mutat Res (2005) 0.82
Environmental genomics: an opportunity for the NIEHS. Environ Health Perspect (2006) 0.79
The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol (2006) 30.90
The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat Biotechnol (2010) 7.08
Performance comparison of one-color and two-color platforms within the MicroArray Quality Control (MAQC) project. Nat Biotechnol (2006) 5.92
ISA software suite: supporting standards-compliant experimental annotation and enabling curation at the community level. Bioinformatics (2010) 5.60
Rat toxicogenomic study reveals analytical consistency across microarray platforms. Nat Biotechnol (2006) 5.14
Toward interoperable bioscience data. Nat Genet (2012) 4.72
The first RSBI (ISA-TAB) workshop: "can a simple format work for complex studies?". OMICS (2008) 4.15
Cross-platform comparability of microarray technology: intra-platform consistency and appropriate data analysis procedures are essential. BMC Bioinformatics (2005) 3.93
A strategy capitalizing on synergies: the Reporting Structure for Biological Investigation (RSBI) working group. OMICS (2006) 3.51
QA/QC: challenges and pitfalls facing the microarray community and regulatory agencies. Expert Rev Mol Diagn (2004) 2.73
The balance of reproducibility, sensitivity, and specificity of lists of differentially expressed genes in microarray studies. BMC Bioinformatics (2008) 2.54
High lipophilicity and high daily dose of oral medications are associated with significant risk for drug-induced liver injury. Hepatology (2013) 2.02
Microarray scanner calibration curves: characteristics and implications. BMC Bioinformatics (2005) 2.02
Assessing batch effects of genotype calling algorithm BRLMM for the Affymetrix GeneChip Human Mapping 500 K array set using 270 HapMap samples. BMC Bioinformatics (2008) 1.98
GOFFA: gene ontology for functional analysis--a FDA gene ontology tool for analysis of genomic and proteomic data. BMC Bioinformatics (2006) 1.72
ArrayTrack: an FDA and public genomic tool. Methods Mol Biol (2009) 1.71
Reproducible and reliable microarray results through quality control: good laboratory proficiency and appropriate data analysis practices are essential. Curr Opin Biotechnol (2007) 1.71
DNA microarrays are predictive of cancer prognosis: a re-evaluation. Clin Cancer Res (2010) 1.69
Study of 202 natural, synthetic, and environmental chemicals for binding to the androgen receptor. Chem Res Toxicol (2003) 1.61
Mining FDA drug labels using an unsupervised learning technique--topic modeling. BMC Bioinformatics (2011) 1.53
Current status of methods for defining the applicability domain of (quantitative) structure-activity relationships. The report and recommendations of ECVAM Workshop 52. Altern Lab Anim (2005) 1.52
Functional and geographical differentiation of candidate balanced polymorphisms in Arabidopsis thaliana. Mol Ecol (2009) 1.43
FDA-approved drug labeling for the study of drug-induced liver injury. Drug Discov Today (2011) 1.42
Comparing next-generation sequencing and microarray technologies in a toxicological study of the effects of aristolochic acid on rat kidneys. Chem Res Toxicol (2011) 1.41
Technical reproducibility of genotyping SNP arrays used in genome-wide association studies. PLoS One (2012) 1.36
Next-generation sequencing and its applications in molecular diagnostics. Expert Rev Mol Diagn (2011) 1.33
Prediction of estrogen receptor binding for 58,000 chemicals using an integrated system of a tree-based model with structural alerts. Environ Health Perspect (2002) 1.31
Phytoestrogens and mycoestrogens bind to the rat uterine estrogen receptor. J Nutr (2002) 1.27
Quality control and quality assessment of data from surface-enhanced laser desorption/ionization (SELDI) time-of flight (TOF) mass spectrometry (MS). BMC Bioinformatics (2005) 1.25
Investigating drug repositioning opportunities in FDA drug labels through topic modeling. BMC Bioinformatics (2012) 1.22
Multi-class cancer classification by total principal component regression (TPCR) using microarray gene expression data. Nucleic Acids Res (2005) 1.19
Perspectives on validation of high-throughput assays supporting 21st century toxicity testing. ALTEX (2013) 1.19
A decade of toxicogenomic research and its contribution to toxicological science. Toxicol Sci (2012) 1.14
Mold(2), molecular descriptors from 2D structures for chemoinformatics and toxicoinformatics. J Chem Inf Model (2008) 1.09
Voluntary exploratory data submissions to the US FDA and the EMA: experience and impact. Nat Rev Drug Discov (2010) 1.08
Multi-class tumor classification by discriminant partial least squares using microarray gene expression data and assessment of classification models. Comput Biol Chem (2004) 1.07
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). PLoS Comput Biol (2011) 1.06
Identification of genes and pathways involved in kidney renal clear cell carcinoma. BMC Bioinformatics (2014) 1.05
Gene expression profile exploration of a large dataset on chronic fatigue syndrome. Pharmacogenomics (2006) 1.04
Quantitative structure-activity relationship methods: perspectives on drug discovery and toxicology. Environ Toxicol Chem (2003) 1.03
The EDKB: an established knowledge base for endocrine disrupting chemicals. BMC Bioinformatics (2010) 1.03
Chemical effects in biological systems--data dictionary (CEBS-DD): a compendium of terms for the capture and integration of biological study design description, conventional phenotypes, and 'omics data. Toxicol Sci (2005) 1.01
Differential gene expression in mouse primary hepatocytes exposed to the peroxisome proliferator-activated receptor alpha agonists. BMC Bioinformatics (2006) 0.98
Meeting report: Validation of toxicogenomics-based test systems: ECVAM-ICCVAM/NICEATM considerations for regulatory use. Environ Health Perspect (2006) 0.98
An FDA bioinformatics tool for microbial genomics research on molecular characterization of bacterial foodborne pathogens using microarrays. BMC Bioinformatics (2010) 0.97
Three new consensus QSAR models for the prediction of Ames genotoxicity. Mutagenesis (2004) 0.96
Toward a checklist for exchange and interpretation of data from a toxicology study. Toxicol Sci (2007) 0.95
Decision forest analysis of 61 single nucleotide polymorphisms in a case-control study of esophageal cancer; a novel method. BMC Bioinformatics (2005) 0.95
Integrating time-course microarray gene expression profiles with cytotoxicity for identification of biomarkers in primary rat hepatocytes exposed to cadmium. Bioinformatics (2005) 0.94
In silico drug repositioning: what we need to know. Drug Discov Today (2012) 0.93
The liver toxicity biomarker study: phase I design and preliminary results. Toxicol Pathol (2009) 0.93
Two new ArrayTrack libraries for personalized biomedical research. BMC Bioinformatics (2010) 0.92
Evaluation of gene expression data generated from expired Affymetrix GeneChip® microarrays using MAQC reference RNA samples. BMC Bioinformatics (2010) 0.92
Biomarkers for drug-induced liver injury. Expert Rev Gastroenterol Hepatol (2010) 0.92
An integrated study of acute effects of valproic acid in the liver using metabonomics, proteomics, and transcriptomics platforms. OMICS (2006) 0.91
EADB: an estrogenic activity database for assessing potential endocrine activity. Toxicol Sci (2013) 0.91
Consensus analysis of multiple classifiers using non-repetitive variables: diagnostic application to microarray gene expression data. Comput Biol Chem (2007) 0.90
ArrayTrack: a free FDA bioinformatics tool to support emerging biomedical research--an update. Hum Genomics (2010) 0.89
An investigation of biomarkers derived from legacy microarray data for their utility in the RNA-seq era. Genome Biol (2014) 0.88
Evaluating variations of genotype calling: a potential source of spurious associations in genome-wide association studies. J Genet (2010) 0.88
Whole genome sequencing of 35 individuals provides insights into the genetic architecture of Korean population. BMC Bioinformatics (2014) 0.88
Mining hidden knowledge for drug safety assessment: topic modeling of LiverTox as a case study. BMC Bioinformatics (2014) 0.88
Critical role of bioinformatics in translating huge amounts of next-generation sequencing data into personalized medicine. Sci China Life Sci (2013) 0.88
Toward predictive models for drug-induced liver injury in humans: are we there yet? Biomark Med (2014) 0.88
High daily dose and being a substrate of cytochrome P450 enzymes are two important predictors of drug-induced liver injury. Drug Metab Dispos (2014) 0.87
Comparative analysis of predictive models for nongenotoxic hepatocarcinogenicity using both toxicogenomics and quantitative structure-activity relationships. Chem Res Toxicol (2011) 0.87
Multiclass Decision Forest--a novel pattern recognition method for multiclass classification in microarray data analysis. DNA Cell Biol (2004) 0.87
A testing strategy to predict risk for drug-induced liver injury in humans using high-content screen assays and the 'rule-of-two' model. Arch Toxicol (2014) 0.86
Maximizing biomarker discovery by minimizing gene signatures. BMC Genomics (2011) 0.86
Shifting from population-wide to personalized cancer prognosis with microarrays. PLoS One (2012) 0.86
Discovering functional modules by topic modeling RNA-Seq based toxicogenomic data. Chem Res Toxicol (2014) 0.85
atBioNet--an integrated network analysis tool for genomics and biomarker discovery. BMC Genomics (2012) 0.85
Microarray analysis distinguishes differential gene expression patterns from large and small colony Thymidine kinase mutants of L5178Y mouse lymphoma cells. BMC Bioinformatics (2006) 0.85
Homology modeling, molecular docking, and molecular dynamics simulations elucidated α-fetoprotein binding modes. BMC Bioinformatics (2013) 0.85
An approach to comparative analysis of chromatographic fingerprints for assuring the quality of botanical drugs. J Chem Inf Comput Sci (2003) 0.84
Competitive molecular docking approach for predicting estrogen receptor subtype α agonists and antagonists. BMC Bioinformatics (2014) 0.84
Selecting a single model or combining multiple models for microarray-based classifier development?--a comparative analysis based on large and diverse datasets generated from the MAQC-II project. BMC Bioinformatics (2011) 0.84
Differential gene expression profiling of mouse skin after sulfur mustard exposure: Extended time response and inhibitor effect. Toxicol Appl Pharmacol (2008) 0.84
QA/QC issues to aid regulatory acceptance of microarray gene expression data. Environ Mol Mutagen (2007) 0.84
Self-self hybridization as an alternative experiment design to dye swap for two-color microarrays. OMICS (2007) 0.82
Incorporating the human gene annotations in different databases significantly improved transcriptomic and genetic analyses. RNA (2013) 0.82
Investigation of reproducibility of differentially expressed genes in DNA microarrays through statistical simulation. BMC Proc (2009) 0.82
Constructing a robust protein-protein interaction network by integrating multiple public databases. BMC Bioinformatics (2011) 0.82
Understanding and predicting binding between human leukocyte antigens (HLAs) and peptides by network analysis. BMC Bioinformatics (2015) 0.82
Predicting idiosyncratic drug-induced liver injury: some recent advances. Expert Rev Gastroenterol Hepatol (2014) 0.81
Is toxicogenomics a more reliable and sensitive biomarker than conventional indicators from rats to predict drug-induced liver injury in humans? Chem Res Toxicol (2011) 0.81
A systems approach for analysis of high content screening assay data with topic modeling. BMC Bioinformatics (2013) 0.81
Does applicability domain exist in microarray-based genomic research? PLoS One (2010) 0.80
Maximum predictive power of the microarray-based models for clinical outcomes is limited by correlation between endpoint and gene expression profile. BMC Genomics (2011) 0.80
Next generation sequencing for profiling expression of miRNAs: technical progress and applications in drug development. J Biomed Sci Eng (2011) 0.80
Very Important Pool (VIP) genes--an application for microarray-based molecular signatures. BMC Bioinformatics (2008) 0.80
ebTrack: an environmental bioinformatics system built upon ArrayTrack. BMC Proc (2009) 0.80
Comprehensively identifying and characterizing the missing gene sequences in human reference genome with integrated analytic approaches. Hum Genet (2013) 0.80
The accurate prediction of protein family from amino acid sequence by measuring features of sequence fragments. J Comput Biol (2009) 0.80
Molecular docking to identify associations between drugs and class I human leukocyte antigens for predicting idiosyncratic drug reactions. Comb Chem High Throughput Screen (2015) 0.80
Evaluations of the trans-sulfuration pathway in multiple liver toxicity studies. Toxicol Appl Pharmacol (2008) 0.79
Classification of cDNA array genes that have a highly significant discriminative power due to their unique distribution in four brain regions. DNA Cell Biol (2004) 0.79